FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2036892901> ?p ?o ?g. }

• W2036892901 endingPage "915" @default.
• W2036892901 startingPage "902" @default.
• W2036892901 abstract "<h2>Abstract</h2> Bivalirudin has gained ground against unfractionated heparin (UFH) in percutaneous coronary interventions (PCI), due to a reported better safety profile. However, whether bivalirudin may provide also advantages in clinical outcome beyond the known benefits in major bleedings, is still a debated matter and was, therefore, the aim of present meta-analysis of randomized trials, evaluating efficacy and safety of bivalirudin as compared with UFH in PCI. <h3>Methods and study outcomes</h3> Literature archives (Pubmed, EMBASE, Cochrane) and main scientific sessions were scanned. Primary endpoint was overall mortality. Secondary endpoints were: 1) mortality within 30-days; 2) overall and within 30-days non fatal myocardial infarction; 3) overall and within 30-days stent thrombosis. Safety endpoints were major bleedings (per protocol definition or TIMI classification). A prespecified analysis was conducted according to clinical presentation (Elective, ACS, STEMI). <h3>Results</h3> A total of 22 randomized clinical were finally included, involving 40156 patients randomized to bivalirudin (52.9%) or to UFH (47.1%). Death occurred in 1100 (2.8%) of patients, with no difference between bivalirudin and UFH (2.7% vs 2.8% OR[95%C]=0.94[0.83,-.06], p=0.32, phet=0.48). The results did not change according to clinical presentation. By meta-regression analysis, the effects on mortality were not related to patients risk profile (r=−0.38(−0.89-0.14), p=0.15) or the reduction in bleeding complications (r=−0.008(−0.86-0.85), p=0.98). A significant increase in short-term stent thrombosis was observed with bivalirudin (OR[95%CI]=1.42 [1.10-1.83], p=0.006). However, Bivalirudin significantly reduced bleedings according to both study protocol definition (OR[95%CI]=0.62[0.56-0.69],p<0.00001; phet=0.0003) or TIMI major criteria (OR[95%CI]=0.65[0.53-0.79],p<0.0001, phet=0.95). <h3>Conclusions</h3> In present meta-analysis, among patients undergoing PCI, bivalirudin, as compared with UFH, is associated with a significant reduction in major bleeding complications that, however, does not translate into mortality benefits. Furthermore, bivalirudin is associated with higher rate of 30-days stent thrombosis and recurrent MI among STEMI patients." @default.
• W2036892901 created "2016-06-24" @default.
• W2036892901 creator A5000400608 @default.
• W2036892901 creator A5015479782 @default.
• W2036892901 creator A5024732332 @default.
• W2036892901 creator A5064670948 @default.
• W2036892901 creator A5068649190 @default.
• W2036892901 date "2015-05-01" @default.
• W2036892901 modified "2023-09-25" @default.
• W2036892901 title "Bivalirudin as compared to unfractionated heparin in patients undergoing percutaneous coronary revascularization: A meta-analysis of 22 randomized trials" @default.
• W2036892901 cites W1491170957 @default.
• W2036892901 cites W1517112829 @default.
• W2036892901 cites W1573872903 @default.
• W2036892901 cites W161671725 @default.
• W2036892901 cites W1814413446 @default.
• W2036892901 cites W1914615055 @default.
• W2036892901 cites W1967003802 @default.
• W2036892901 cites W1968369112 @default.
• W2036892901 cites W1971157734 @default.
• W2036892901 cites W1971548461 @default.
• W2036892901 cites W1979949191 @default.
• W2036892901 cites W1988996988 @default.
• W2036892901 cites W1990864736 @default.
• W2036892901 cites W2002418155 @default.
• W2036892901 cites W2004589881 @default.
• W2036892901 cites W2006675975 @default.
• W2036892901 cites W2012932483 @default.
• W2036892901 cites W2017977108 @default.
• W2036892901 cites W2020099275 @default.
• W2036892901 cites W2024692328 @default.
• W2036892901 cites W2032167693 @default.
• W2036892901 cites W2033481411 @default.
• W2036892901 cites W2034358332 @default.
• W2036892901 cites W2040318406 @default.
• W2036892901 cites W2044718948 @default.
• W2036892901 cites W2045218734 @default.
• W2036892901 cites W2046027264 @default.
• W2036892901 cites W2048395382 @default.
• W2036892901 cites W2059627219 @default.
• W2036892901 cites W2067274524 @default.
• W2036892901 cites W2070261961 @default.
• W2036892901 cites W2073146905 @default.
• W2036892901 cites W2078903829 @default.
• W2036892901 cites W2078904498 @default.
• W2036892901 cites W2082333685 @default.
• W2036892901 cites W2085413583 @default.
• W2036892901 cites W2099409915 @default.
• W2036892901 cites W2102296549 @default.
• W2036892901 cites W2102695511 @default.
• W2036892901 cites W2103428481 @default.
• W2036892901 cites W2108122635 @default.
• W2036892901 cites W2111440117 @default.
• W2036892901 cites W2114758846 @default.
• W2036892901 cites W2119311183 @default.
• W2036892901 cites W2126100665 @default.
• W2036892901 cites W2127094247 @default.
• W2036892901 cites W2130652855 @default.
• W2036892901 cites W2131720908 @default.
• W2036892901 cites W2134471771 @default.
• W2036892901 cites W2140387401 @default.
• W2036892901 cites W2142825093 @default.
• W2036892901 cites W2143763771 @default.
• W2036892901 cites W2149933092 @default.
• W2036892901 cites W2152193032 @default.
• W2036892901 cites W2157529011 @default.
• W2036892901 cites W2161134681 @default.
• W2036892901 cites W2318314956 @default.
• W2036892901 cites W2413674647 @default.
• W2036892901 cites W4238696256 @default.
• W2036892901 cites W95276241 @default.
• W2036892901 doi "https://doi.org/10.1016/j.thromres.2015.03.004" @default.
• W2036892901 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25772138" @default.
• W2036892901 hasPublicationYear "2015" @default.
• W2036892901 type Work @default.
• W2036892901 sameAs 2036892901 @default.
• W2036892901 citedByCount "15" @default.
• W2036892901 countsByYear W20368929012015 @default.
• W2036892901 countsByYear W20368929012016 @default.
• W2036892901 countsByYear W20368929012017 @default.
• W2036892901 countsByYear W20368929012018 @default.
• W2036892901 countsByYear W20368929012020 @default.
• W2036892901 countsByYear W20368929012021 @default.
• W2036892901 crossrefType "journal-article" @default.
• W2036892901 hasAuthorship W2036892901A5000400608 @default.
• W2036892901 hasAuthorship W2036892901A5015479782 @default.
• W2036892901 hasAuthorship W2036892901A5024732332 @default.
• W2036892901 hasAuthorship W2036892901A5064670948 @default.
• W2036892901 hasAuthorship W2036892901A5068649190 @default.
• W2036892901 hasConcept C126322002 @default.
• W2036892901 hasConcept C141071460 @default.
• W2036892901 hasConcept C164705383 @default.
• W2036892901 hasConcept C168563851 @default.
• W2036892901 hasConcept C203092338 @default.
• W2036892901 hasConcept C2777565915 @default.
• W2036892901 hasConcept C2777995511 @default.
• W2036892901 hasConcept C2778583881 @default.
• W2036892901 hasConcept C2780400711 @default.
• W2036892901 hasConcept C45393284 @default.

• next